As CD133 is widely considered as a classic tumor stem cell marker,[48, 49] we elected to culture primary tumor cells from patients with CRC in vitro, and sorted the CD133‐ and CD133+ cells for sphere and colony formation assays. This evidence concerns the gene PROM1 and neoplasm.